Universal-Beteiligungs- und Servicegesellschaft
PTCT icon

Universal-Beteiligungs- und Servicegesellschaft’s PTC Therapeutics PTCT Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1M Buy
135,633
+5,951
+5% +$430K 0.02% 615
2026
Q1 		$8.84M Sell
129,682
-21,719
-14% -$1.54M 0.02% 648
2025
Q4 		$11.5M Buy
151,401
+19,300
+15% +$1.4M 0.02% 564
2025
Q3 		$8.11M Buy
132,101
+7,761
+6% +$404K 0.01% 668
2025
Q2 		$6.07M Sell
124,340
-20,370
-14% -$967K 0.01% 747
2025
Q1 		$7.37M Buy
144,710
+36,365
+34% +$1.81M 0.01% 664
2024
Q4 		$4.89M Buy
+108,345
New +$4.64M 0.01% 713

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's PTCT Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its PTC Therapeutics (PTCT) stake by 4.6% in Q2 2026, buying an estimated $430K and bringing the position to 135,633 shares worth $11.1M. The position accounts for 0.02% of the portfolio, ranked #615.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in PTCT in Q4 2024 and has held it in 7 quarters since. The position peaked at $11.5M in Q4 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 135,633 shares of PTC Therapeutics worth $11.1M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 5,951 PTC Therapeutics shares in Q2 2026, an estimated $430K.
  • PTC Therapeutics made up 0.02% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #615 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in PTC Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's PTC Therapeutics position peaked at $11.5M in Q4 2025.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.